In fiscal year 2025, Daesung Microbiological Labs (036480) reported revenue of 26.0 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 26.0 billion KRW | 714 million KRW | 598 million KRW | [source] |
| 2024 | 23.8 billion KRW | -1.6 billion KRW | -1.8 billion KRW | [source] |
| 2023 | 25.6 billion KRW | -689 million KRW | -680 million KRW | [source] |
| 2022 | 25.5 billion KRW | -328 million KRW | 1.7 billion KRW | [source] |
| 2021 | 24.0 billion KRW | 337 million KRW | 866 million KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 58.0 billion KRW | 22.6 billion KRW | 35.4 billion KRW | [source] |
| 2024 | 58.4 billion KRW | 23.2 billion KRW | 35.1 billion KRW | [source] |
| 2023 | 64.3 billion KRW | 26.9 billion KRW | 37.3 billion KRW | [source] |
| 2022 | 65.1 billion KRW | 26.3 billion KRW | 38.8 billion KRW | [source] |
| 2021 | 62.6 billion KRW | 25.6 billion KRW | 37.0 billion KRW | [source] |
